reduced

Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress

– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – – Rademikibart reduced…

3 weeks ago

KBRA Comments on Amendment to Sunnovas Loan Guarantee Agreement with DOE

NEW YORK--(BUSINESS WIRE)--#creditratingagency--In an 8-K filing with the Securities and Exchange Commission on May 29, 2025, Sunnova Energy Corporation (Sunnova)…

1 month ago